Cargando…

Post-Arsphenamine Blood Dyscrasias

Detalles Bibliográficos
Autores principales:	Rajam, R. V., Tampi, R. Balachandran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1938
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219193/ https://www.ncbi.nlm.nih.gov/pubmed/29014215

Ejemplares similares

EXPERIMENTAL OBSERVATIONS ON THE "CURE" OF SYPHILIS IN THE RABBIT WITH ARSPHENAMINE
por: Chesney, Alan M., et al.
Publicado: (1924)

Opium Dyscrasia
por: Moore,
Publicado: (1886)

Pus Dyscrasia
por: Barrett, W. C.
Publicado: (1881)

SUPERINFECTION IN EXPERIMENTAL SYPHILIS FOLLOWING THE ADMINISTRATION OF SUBCURATIVE DOSES OF ARSPHENAMINE OR NEOARSPHENAMINE
por: Brown, Wade H., et al.
Publicado: (1921)

The Effect of Arsenic Preparations (Neoarsphenamine and Silver Arsphenamine) on the Protein Fractions of Blood Plasma in Syphilis and Disseminated Sclerosis
por: Porter, D. C.
Publicado: (1936)

STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS : III. ANAPHYLAXIS INDUCED BY ARSPHENAMINE
por: Landsteiner, K., et al.
Publicado: (1936)

STUDIES IN EXPERIMENTAL SYPHILIS : III. FURTHER OBSERVATIONS ON THE POSSIBILITY OF CURE OF SYPHILIS IN THE RABBIT WITH ARSPHENAMINE.
por: Chesney, Alan M., et al.
Publicado: (1925)

Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients
por: Shiri, M., et al.
Publicado: (2022)

Telomerase activity in plasma cell dyscrasias
por: Xu, D, et al.
Publicado: (2001)

Basic Aural Dyscrasia and Vascular Deafness
Publicado: (1887)

Basic Aural Dyscrasia and Vascular Deafness
Publicado: (1886)

Ocular complications of plasma cell dyscrasias
por: Singh, Rohan Bir, et al.
Publicado: (2023)

Mutational landscape reflects the biological continuum of plasma cell dyscrasias
por: Rossi, A, et al.
Publicado: (2017)

Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
por: Rajapreyar, Indranee, et al.
Publicado: (2020)

The Distribution and Nature of Sprue, with Notes on the Pathology of Intestinal Dyscrasias
por: Brown, W. Carnegie
Publicado: (1907)

A case of plasma cell dyscrasia presenting as nonscarring alopecia
por: Nia, Benjamin, et al.
Publicado: (2021)

Crusted Scabies in Systemic Sclerosis with Plasma Cell Dyscrasia
por: Nikam, Balkrishna P., et al.
Publicado: (2018)

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
por: Morelli, Eugenio, et al.
Publicado: (2020)

Imaging for Plasma Cell Dyscrasias: What, When, and How?
por: Guha, Amrita, et al.
Publicado: (2022)

COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination
por: Shah, Mansi R., et al.
Publicado: (2022)

Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias
por: Janjetovic, Snjezana, et al.
Publicado: (2021)

Value of PET-CT in plasma cell dyscrasias: a literature and pictorial review
por: Aggarwal, R, et al.
Publicado: (2015)

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
por: Golombick, Terry, et al.
Publicado: (2008)

How I treat elderly patients with plasma cell dyscrasias
por: Gavriatopoulou, Maria, et al.
Publicado: (2018)

Leptomeningeal isolated infiltration in plasma cell dyscrasia associated to HIV
por: Sprenger, Flávia, et al.
Publicado: (2022)

Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis
por: Baljevic, Muhamed
Publicado: (2022)

COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering
por: Farina, A., et al.
Publicado: (2021)

Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia
por: Foster, Jessica, et al.
Publicado: (2017)

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
por: Jasiński, Marcin, et al.
Publicado: (2021)

C-src Enriched Serum Microvesicles Are Generated in Malignant Plasma Cell Dyscrasia
por: Di Noto, Giuseppe, et al.
Publicado: (2013)

Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study.
por: Danova, M., et al.
Publicado: (1990)

Quantitation of Monoclonal Plasma Cells in Bone Marrow Biopsies in Plasma Cell Dyscrasia
por: Markey, G. M., et al.
Publicado: (2003)

Cutaneous Vasculitis: An Unusual Presentation of a Biclonal Nodal Plasma Cell Dyscrasia
por: Swan, D., et al.
Publicado: (2017)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
por: Zambello, Renato, et al.
Publicado: (2020)

Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT
por: Brandelik, S. C., et al.
Publicado: (2021)

Symmetrical Periorbital Yellow Plaques in a Patient with Haematological Dyscrasia: A Quiz
por: COZZANI, Emanuele, et al.
Publicado: (2021)

A Comparative Study of the Modified Kline Test with the Wassermann and Kahn Tests on 946 Blood Samples
por: Seshadrinathan, N., et al.
Publicado: (1936)

The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
por: Hemminki, Kari, et al.
Publicado: (2016)

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias
por: Roccaro, Aldo M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gcgsmi7cpva50k72sa3bbdnr7i